Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer - Concepedia

Concepedia

Publication | Closed Access

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

787

Citations

21

References

1999

Year

Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar, Patricia LoRusso, Irene Kuter, Charles L. Vogel, B Osterwalder, Hans‐Ulrich Burger, C. Brown, T. Griffin

Journal of Clinical Oncology

Abstract

Capecitabine is an active drug in the treatment of paclitaxel-refractory metastatic breast cancer. It has a favorable toxicity profile with the added advantage of being an oral drug administered at home.

References

	Year	Citations

Page 1